IP Library › Granted Patent US 11,786,729
Granted Patent B2
US 11,786,729 · App. 17/347,865 · Granted Oct 17, 2023

Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy

Inventors: Bradford Evan Gliner (Sammamish, WA); Allen Wyler (Seattle, WA); Brad Fowler (Woodinville, WA); W. Douglas Sheffield (Seatac, WA); Richard Kuntz (Lakebay, WA); Kent Leyde (Redmond, WA); Leif R. Sloan (Seattle, WA)
Assignee: Advanced Neuromodulation Systems, Inc.
A61N1/3606A61N1/36135A61N1/36146G06F13/385H04L49/90H04L49/901H04L67/565H04L67/568A61N1/0531A61N1/0534A61N1/36064A61N1/36067A61N1/36082A61N1/36103A61N1/37252Y02D10/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,729
App. No.
17/347,865
Granted
Oct 17, 2023
Kind
B2
Abstract

Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy are disclosed. In one embodiment, a system and/or method may apply electromagnetic stimulation to a patient's nervous system over a first time domain according to a first set of stimulation parameters, and over a second time domain according to a second set of stimulation parameters. The first and second time domains may be sequential, simultaneous, or nested. Stimulation parameters may vary in accordance with one or more types of duty cycle, amplitude, pulse repetition frequency, pulse width, spatiotemporal, and/or polarity variations. Stimulation may be applied at subthreshold, threshold, and/or suprathreshold levels in one or more periodic, aperiodic (e.g., chaotic), and/or pseudo-random manners. In some embodiments stimulation may comprise a burst pattern having an interburst frequency corresponding to an intrinsic brainwave frequency, and regular and/or varying intraburst stimulation parameters. Stimulation signals providing reduced power consumption with at least adequate symptomatic relief may be applied prior to moderate or significant power source depletion.

Claims (22)

1. A method of treating chronic pain in a patient using spinal cord stimulation (SCS), comprising:

establishing a wireless communication session, using a controller device, with an implantable pulse generator (IPG) that is adapted to generate electrical stimulation for application to neural tissue of the patient according to programmed therapy parameters, wherein the IPG comprises a header structure connected to one or more implantable stimulation leads with one or more electrodes placed in an epidural space of the patient for stimulation of spinal cord fibers of the patient; and

programming therapy parameters for SCS for the patient during the wireless communication session by communicating the programmed therapy parameters from the controller device to the IPG, wherein the controller device is configured to control the IPG to direct an application of electrical stimulation to the patient in a manner such that the electrical stimulation has a burst frequency and an intra-burst frequency greater than the burst frequency, wherein the controller device directs application of the electrical stimulation according to a duty cycle with stimulation-on periods where electrical stimulation is applied with intervening stimulation-off periods where electrical stimulation is temporarily halted between respective stimulation on-periods, and wherein the duty cycle stimulation-on periods and stimulation-off periods are controlled by a programmable duty cycle parameter set by communication with the controller device.

2. The method of claim 1 wherein the burst frequency varies from burst to burst.

3. The method of claim 1 wherein the burst frequency is generally similar to natural brainwaves.

4. The method of claim 3 wherein the natural brainwaves are selected from a group consisting of alpha, beta, gamma, delta, or theta frequency bands.

5. The method of claim 1 wherein the intra-burst frequency is about 50 Hz to about 500 Hz.

6. The method of claim 1 wherein the electrical stimulation is directed to different electrodes.

7. The method of claim 6 wherein the different electrodes comprise stimulation signal return electrodes configured to apply stimulation signals to a target neural population.

8. The method of claim 1 wherein the electrical stimulation comprises generation of one or more stimulation signals comprising a plurality of biphasic pulses.

9. The method of claim 8 wherein at least one of the plurality of biphasic pulses comprises a symmetric biphasic waveform and wherein at least another of the plurality of biphasic pulses comprises an asymmetric biphasic waveform.

10. The method of claim 1 wherein the programmed therapy parameters include at least one of a pulse repetition frequency, a first peak current amplitude corresponding to a first pulse phase, and a second peak current amplitude corresponding to a second pulse phase.

11. The method of claim 1 wherein the electrical stimulation comprises generation of a direct current (DC) signal.

12. The method of claim 1 wherein the electrical stimulation comprises generation of a first plurality of stimulation signals at one or more suprathreshold amplitude levels configured to raise neural membrane potentials corresponding to a target neural population to elicit one or more action potentials in the target neural population.

13. The method of claim 12 wherein the electrical stimulation further comprises generation of a second plurality of stimulation signals at one or more subthreshold amplitude levels configured to raise neural membrane potentials corresponding to the target neural population without eliciting the one or more action potentials in the target neural population.

14. The method of claim 13 wherein the one or more subthreshold amplitude levels corresponds to a particular fraction of a lowest test stimulation signal amplitude at which a patient exhibits an electrophysiological signal in response to the electrical stimulation.

15. The method of claim 1 , wherein the controller device is further configured to control the IPG to direct an application of electrical stimulation to the patient comprising neuro-burst stimulation to facilitate enhanced neural stimulation efficacy while reducing an amount of power consumed by the IPG while providing the electrical stimulation.

16. The method of claim 15 wherein the neuro-burst stimulation comprises theta-burst stimulation configured to facilitate enhanced recovery from neurological dysfunction.

17. The method of claim 15 wherein the electrical stimulation comprises a first set of stimulation frequency characteristics comprising a first pulse repetition frequency applied during a first time interval and a second set of stimulation frequency characteristics comprising a second pulse repetition frequency distinct from the first pulse repetition frequency applied during a second time interval distinct from the first time interval.

18. The method of claim 17 wherein the second pulse repetition frequency corresponds to a theta-burst pattern.

19. The method of claim 1 , wherein the controller device is configured to control the IPG to direct an application of electrical stimulation to the patient in a manner such that an electrical stimulation output has particular parameter values determined in accordance with an occurrence distribution.

20. The method of claim 1 , wherein the controller device is configured to control the IPG to direct an application of electrical stimulation to the patient in a manner such that an electrical stimulation output includes aperiodic stimulation signals based on an iterative function.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: GLINER, BRADFORD EVAN; WYLER, ALLEN; FOWLER, BRAD; SHEFFIELD, W. DOUGLAS; KUNTZ, RICHARD; LEYDE, KENT; SLOAN, LEIF R.
To: NORTHSTAR NEUROSCIENCE, INC.
Reel/Frame 059399/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: NORTHSTAR NEUROSCIENCE, INC.
To: ADVANCED NEUROMODULATION SYSTEMS, INC.
Reel/Frame 059400/0248 →
Continuity (8)
Continuation 15805052 · Nov 6, 2017
Continuation 14942800 · Nov 16, 2015
Continuation 14101189 · Dec 9, 2013
Continuation 13179133 · Jul 8, 2011
Continuation 12327711 · Dec 3, 2008
Division 11182713 · Jul 15, 2005
Provisional Application 60588406 · Jul 15, 2004
Related Publication 20210308456A1 · Oct 7, 2021